Featured

Featured from APO|APE News: Cancer care, diagnostic pathology, and precision medicine.

Oncology

Johnson & Johnson Turned Rybrevant's Survival Win Into a Once-a-Month Injection, With More Planned for Amivantamab

August 26, 2026

Oncology

AstraZeneca Rebuilds Breast Cancer Treatment Around Enhertu, Datroway and a Blood Test

August 26, 2026

Immuno-Oncology

Merck and Moderna Report Positive Phase 3 Interim Readout for Individualized mRNA Therapy Intismeran in Resected Melanoma

August 22, 2026

ADCs & Radiopharma

IU Health Launches a $40 Million Theranostics Center of Excellence It Will Run Statewide

August 19, 2026

Pathology

"Adapt or Become Irrelevant": Puerto Rico Lab CEO and Natera Pathologist Tell Journal of Clinical Pathology Readers to Become Diagnostic Architects

August 17, 2026